Amarex Clinical Research
29
6
6
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
27.6%
8 terminated/withdrawn out of 29 trials
60.0%
-26.6% vs industry average
3%
1 trials in Phase 3/4
83%
10 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma
Role: collaborator
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
Role: collaborator
Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation
Role: collaborator
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
Role: collaborator
Clinical Pre-screening Protocol for Ovarian Cancer
Role: collaborator
Study of PARPi 2X-121 as Monotherapy and in Combination With Dovitinib in Patients With Advanced Solid Tumors
Role: collaborator
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
Role: collaborator
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
Role: collaborator
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Role: collaborator
PRO 140 in Treatment-Experienced HIV-1 Subjects
Role: collaborator
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
Role: collaborator
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Role: collaborator
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
Role: collaborator
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Role: collaborator
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19
Role: collaborator
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
Role: collaborator
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation
Role: collaborator
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers
Role: collaborator
Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection
Role: collaborator
Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer
Role: collaborator